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SEVERAL WORKERS have demonstrated
elaboration of physiologically important
entities such as placental hormones by
neoplastic cells (Braunstein et al., 1975).
The production of human placental lacto-
gen (hPL) has been reported so far only
in association with malignant tumours
(Weintraub & Rosen, 1971; Gaspard et al.,
1973; Rosen et al., 1975; Sheth et al.,
1977). Its presence in various non-
cancerous conditions has not been estab-
lished except for one report on its detec-
tion in normal testes of a patient with
prostate cancer (Payne & Ryan, 1972).
The present communication deals with
our investigations on the association of
hPL, if any, with fibroadenoma of breast,
a benign tumour. Using a sensitive radio-
immunoassay (RIA) for hPL, extracts of
tumour samples as well as pre- and post-
operative sera from patients were exam-
ined. The results indicate association of
hPL with fibroadenoma of the breast in a
significant proportion of the patients.
Patients.-Women included in these
investigations were those examined at the
Tata Memorial Hospital, Bombay. Clinic-
ally, all the patients had hard, freely
mobile, small-to-medium-size nodules in
the substance of the breast, but no
palpable axillary nodes. Mammography
revealed well circumscribed uniform
shadows with or without a rim of macro-
calcification, and absence ofother features
suggesting carcinoma. On histopatho-
logical examination, tumour samples in
all cases showed classical features of
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fibroadenoma, most belonging to the
extra-medullary type.
Serum samples.-Blood samples were
obtained from 30 patients with histo-
logically confirmed fibroadenomas of the
breast. Postoperative samples were ob-
tained from 6 of these patients between 1
week and 10 months (as shown in Table
II) after excision ofthe tumours. The sera,
separated from clotted blood, were stored
at - 20°C until further use.
Tissue samples.-Twenty-seven tumour
samples were obtained from 21 patients.
Amongst these, 12 were from 6 patients
with bilateral tumours, and the remaining
15 from the patients with unilateral
tumours. Normal breast tissue adjacent to
the fibroadenoma was obtained wherever
possible (6 patients). Tissue samples were
stored at -20TC before processing.
Radioimmunoassay.-The tissues were
weighed and homogenized in ice-cold
O-OlM phosphate-buffered saline (PBS) pH
7 0. The homogenates were spun at 4°C
at 800 g to remove fat collected at the top
of the homogenate, and recentrifuged at
15,000 g for 30 min. The supernatants
were used for RIA. Reagents for RIA of
hPL were generously provided by NIA-
MDD, Bethesda, U.S.A. Highly specific
antiserum to hPL was obtained from the
Institute for Research in Reproduction,
Bombay. The antiserum showed no cross-
reactivity with human LH, FSH, TSH,
GH or Prl, at a level of 100 ng per assay
tube. Carrier-free 125J was obtained from
Radiochemical Centre, Amersham. hPLhPL IN FIBROADENOMA OF BREAST
was iodinated by the method of Green-
wood et al. (1963) as modified by Midgley
(1966). The specific activity ofthe labelled
hormone was 100-150/,uCi/pg. The assay
procedure was the same as described by
Sheth et al. (1977). All the serum samples
and tissue extracts were examined in
duplicate, using aliquots of 200 and 400 pl
per assay tube. The samples were con-
sidered positive only when total precipit-
able counts were less than 80% of the
counts in zero-antigen tubes (Figure). The
sensitivity of the assay was 0 3 ng per
assay tube. The intra-assay variation of
the results was < 2% and the inter-assay
variation was < 5%. All samples were
assayed within 30 days of collection.
As can be seen from the values given in
Table I, none of the serum samples from
non-pregnant women or normal men con-
tained hPL, whereas 9/30 patients (30%)
with fibroadenomas yielded serum samples
containing hPL in the range 1-5.6 ng/ml.
Table II gives the data on tissue ex-
tracts and pre- and post-operative sera
from the corresponding patients. Out of 21
patients examined for their tumour ex-
tracts, 9 were positive (negative patients
are not included in the Table). The 9
patients (6 with unilateral and 3 with
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FIGuRE.-Logit-log plot of the human
placental lactogen standard.
TABLE I.-Retrospective incidence ofserum
hPL+ cases inpatients withfibroadenoma
ofbreast
Total
Serum donors examined
Patients with
fibroadenoma 30
Normal non-pregnant
women 30
Normal men 30
No.
hPL+
(%)
Serum
hPL
(ng/ml)
9 (30) 1-5-6
- (0) N.D.
- (0) N.D.
N.D.=Not detectable.
bilateral tumours)with hPL+ tumours also
showed hPL in their preoperative sera.
On the other hand, the 12 patients (9 with
unilateral and 3 with bilateral tumours)
whose tumours had no hPL had no detect-
able hPL in circulation. Furthermore, the
postoperative sera collected from 7 out
of 9 patients with hPL in their tumours
and preoperative sera became hPL- when
examined between 1 week to 6 months
after excision offibroadenoma.
Ectopic secretion of hPL by benign
tumours has not been reported so far. In
the present investigations, however, the
sensitive RIA detectedhPL in a significant
proportion of tumour samples and pre-
operative sera from patients with fibro-
adenoma of the breast. Control samples
assayed simultaneously with the same
reagents gave no false-positive results.
Moreover, the inhibition curves for hPL+
extracts and sera were parallel to those
obtained with standard hPL samples.
The presence ofhPL in tumour extracts
and preoperative sera, and its non-
detectability in the postoperative sera,
provide indirect evidence for the elabora-
tion of hPL by the tumours.
Interestingly, the studies on bilateral
fibroadenomas (Table II) showed that the
tumours from both the breasts were hPL+.
Positive results with bilateral tumours
suggest the possibility of a common factor
governing the ectopic secretion in both the
tumours. Another interesting observation
from the present investigation is that
normal breast tissue adjacent to hPL+
fibroadenoma was negative for hPL in all
0-2 0-4 0-6 1-6 3-2 6-4 16-8 2&6
ng HORMONE
259
CIO c0
-i260 N. A. SHETH, M. A. ADIL, J. N. SURAIYA AND A. R. SHETH
TABLE II.-hPL in pre- and post-operative serum and tumour of individual patient with
fibroadenoma of breast
Pre-op.
Pt Age serum Tumour Normal Post-op. serum
No. (yrs) (ng/ml) (ng/gwetwt) breast* (ng/ml)
1 22 3-5 19-0 -ve -ve (3weeks)t
2 23 5-6 240 -ve (3 weeks)
3 33 4-2 28-0
4 35 2-0 20-0 -ve -ve (3 weeks)
5 35 3-4 20-4 3-8 (1 week)
-ve (1, 4, 9, 10months)
6 42 2-2 21-0 -ve -ve (6 months)
7 15 1-0 7-2; 7-2t -ve
8 21 5-2 15-0; 15-0 -ve
9 24 4-7 20-0; 20-0 -ve -ve (2 weeks)
* Adjacent to fibroadenoma of same patient.
t Period after the operation when serum was collected.
I One value from each bilateral fibroadenoma.
6 patients examined. In contrast, similar
tissue adjacent to carcinoma of breast
revealed hPL whenever the carcinoma
had detectable hPL (unpublished observa-
tion). The fact that fibroadenoma is well
delineated from the surrounding breast
tissue indicates encapsulation (Haagensen,
1971) which may be responsible for the
absence of hPL in tissue adjacent to hPL+
fibroadenoma.
Our detection of circulating hPL in
fibroadenoma patients contrasts with simi-
lar studies by Rosen et al. (1975) and
Sheth et al. (1977). Both those reports,
however, dealt with smaller numbers of
patients.
It may be ofinterest that RIA ofa hCG
carried out at the same sensitivity level as
for hPL did not reveal fi hCG in sera of
patients with fibroadenoma of breast, and
confirmed our earlier observations (Sheth
et al., 1974). Greater secretion ofhPL than
hCG by fibroadenomas of breast is note-
worthy. hPL is known to be mammo-
trophic in lower animals and stimulatory
for mammary-gland growth and dysplasia
in mice (Yanai & Nagasawa, 1973).
Recent reports provide evidence for hPL-
mediated stimulation of DNA synthesis
in organ cultures of benign human breast
tumours (Welsch et at., 1978) and mito-
genicity of hPL for ductal epithelium in
human benign breast tumours grown in
organ culture (Welsch et at., 1978) and in
athymic nude mice (McManus et al.,
1978). These reports suggest a key role for
hPL in the aetiology of human benign
breast tumours. It is possible that hPL
secreted by fibroadenoma plays a local
role in tumourgrowth.
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